A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects

NCT06562088 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subject

Interventions

DRUG: HDM1002 and rifampicin
DRUG: HDM1002 and itraconazole

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.